[go: up one dir, main page]

AU2001291160A1 - Fatty acid synthase inhibitors - Google Patents

Fatty acid synthase inhibitors

Info

Publication number
AU2001291160A1
AU2001291160A1 AU2001291160A AU9116001A AU2001291160A1 AU 2001291160 A1 AU2001291160 A1 AU 2001291160A1 AU 2001291160 A AU2001291160 A AU 2001291160A AU 9116001 A AU9116001 A AU 9116001A AU 2001291160 A1 AU2001291160 A1 AU 2001291160A1
Authority
AU
Australia
Prior art keywords
fatty acid
acid synthase
synthase inhibitors
inhibitors
fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291160A
Inventor
Robert A Daines
Israil Pendrak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2001291160A1 publication Critical patent/AU2001291160A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001291160A 2000-09-22 2001-09-20 Fatty acid synthase inhibitors Abandoned AU2001291160A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23460000P 2000-09-22 2000-09-22
US60234600 2000-09-22
PCT/US2001/029490 WO2002024197A1 (en) 2000-09-22 2001-09-20 Fatty acid synthase inhibitors

Publications (1)

Publication Number Publication Date
AU2001291160A1 true AU2001291160A1 (en) 2002-04-02

Family

ID=22882034

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291160A Abandoned AU2001291160A1 (en) 2000-09-22 2001-09-20 Fatty acid synthase inhibitors

Country Status (4)

Country Link
EP (1) EP1318806A4 (en)
JP (1) JP2004513887A (en)
AU (1) AU2001291160A1 (en)
WO (1) WO2002024197A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME03564B (en) 2013-03-13 2020-07-20 Forma Therapeutics Inc 2-hydroxy-1-{4-[(4-phenylphenyl)carbonyl]piperazin-1-yl}ethan-1-one derivatives and related compounds as fatty acid synthase (fasn) inhibitors for the treatment of cancer
TWI767148B (en) 2018-10-10 2022-06-11 美商弗瑪治療公司 Inhibiting fatty acid synthase (fasn)
CN113382633A (en) 2018-10-29 2021-09-10 福马治疗股份有限公司 Solid forms of (4- (2-fluoro-4- (1-methyl-1H-benzo [ d ] imidazol-5-yl) benzoyl) piperazin-1-yl) (1-hydroxycyclopropyl) methanone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175283A (en) * 1990-06-04 1992-12-29 Bristol-Myers Squibb Company Azetidin-2-one derivatives as serine protease inhibitors
US5594134A (en) * 1995-03-31 1997-01-14 Merck & Co., Inc. Process of synthesizing N-acyl auxiliaries

Also Published As

Publication number Publication date
JP2004513887A (en) 2004-05-13
EP1318806A1 (en) 2003-06-18
EP1318806A4 (en) 2004-01-21
WO2002024197A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
AU2001258771A1 (en) -secretase inhibitors
AU7526901A (en) Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
AU2002219555A1 (en) VLA-4 Inhibitors
AU2001270200A1 (en) Fatty acid synthase inhibitors
AU2001278986A1 (en) 3-amino-2-(4-aminocarbonyloxy)phenyl-propionic acid derivatives as alpha-4- integrin inhibitors
AU2001281059A1 (en) Fatty acid synthase inhibitors
AU2001236052A1 (en) Urease inhibitors
AU2001280167A1 (en) Novel propenohydroxamic acid derivatives
AU2002222627A1 (en) Tak1 inhibitors
AU7961300A (en) Kainic acid neurocytotoxicity inhibitors
IL148324A0 (en) Fatty acid synthase inhibitors
AU2001271531A1 (en) Fatty acid synthase inhibitors
AU2002224550A1 (en) Corrosion inhibitors
GB0030284D0 (en) Enzyme inhibitors
AU2001274940A1 (en) Fatty acid synthase inhibitors
AU2002243439A1 (en) Fatty acid synthase inhibitors
IL151250A0 (en) Difluorobutyric acid metalloprotease inhibitors
AU6925500A (en) Fatty acid synthase inhibitors
AU2001271718A1 (en) Fatty acid synthase inhibitors
AU6926500A (en) Fatty acid synthase inhibitors
AU2001291160A1 (en) Fatty acid synthase inhibitors
AU2001284705A1 (en) Fatty acid synthase inhibitors
AUPQ851000A0 (en) Rapid fatty acid delivery
AU2001268853A1 (en) Biocatalyst inhibitors
AU2001269121A1 (en) Substituted amidoalkyl-uracils as parp inhibitors